Related Experiment Video
Updated: Aug 30, 2026

Drug-Induced Sleep Endoscopy (DISE) with Target Controlled Infusion (TCI) and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
Obstructive sleep apnea syndrome due to adenotonsillar hypertrophy in infants
Michal Greenfeld1, Riva Tauman, Ari DeRowe
1Pediatric Intensive Care, Sackler Faculty of Medicine, Pediatric Pulmonology and Center for Sleep Disorders, Dana Children's Hospital, Tel Aviv Sourasky Medical Center, Tel Aviv University, 6 Weizman Street, Tel Aviv 64239, Israel.
Insights
Obstructive sleep apnea syndrome (OSAS) in infants due to adenotonsillar hypertrophy (ATH) is more common than previously thought. Early diagnosis and treatment are crucial for improving infant health and development.
Area of Science:
- Pediatric Sleep Medicine
- Otolaryngology
Background:
- Adenotonsillar hypertrophy (ATH) is a primary cause of obstructive sleep apnea syndrome (OSAS) in children.
- OSAS due to ATH is considered rare in infants, typically affecting children aged 3-6 years.
Purpose of the Study:
- To investigate the occurrence and characteristics of OSAS caused by ATH in infants under 18 months of age.
Main Methods:
- A retrospective study of 29 infants (<18 months) diagnosed with OSAS due to ATH via polysomnography (PSG).
- Data collected included demographics, symptoms, pre/post-operative weight, and developmental assessments.
- Parental questionnaires were used to gather information on symptoms and outcomes.
Main Results:
- Snoring was universal; 72% had sleep apnea, 69% frequent movements, 62% mouth breathing, and 38% recurrent awakenings.
- Infants experienced significant weight loss pre-operatively (67th to 42nd percentile) and weight gain post-operatively (to 59th percentile).
- Developmental delay was noted in 17% pre-operatively, resolving in 60% post-treatment; symptom recurrence occurred in 26%.
Conclusions:
- Infantile OSAS due to ATH is a distinct clinical entity in infants.
- Key features include male predominance, high incidence of preterm infants, failure to gain weight, and a notable recurrence rate post-surgery.
- Pediatricians and otolaryngologists should recognize "early OSAS" in infants presenting with these symptoms.
Objective:
Adenotonsillar hypertrophy (ATH) is the leading cause for obstructive sleep apnea syndrome (OSAS) in children. The peak age for adenoid and tonsillar hypertrophy and related OSAS is 3-6 years. It has been suggested that OSAS due to ATH is extremely rare in infants. The purpose of the present study was to delineate OSAS due to ATH in infants.
Methods:
Twenty-nine consecutive infants <18 months of age who underwent polysomnography (PSG) and were diagnosed with OSAS due to ATH were studied. A pediatric sleep questionnaire was completed by parents of all infants. Information regarding demographic variables, referring physician specialty, assessment of infant's development and recurrence of symptoms post treatment was collected. Pre and post surgery body weight and developmental assessment by parents were evaluated.
Results:
The mean age of adenotonsillectomy was 12.3+/-3.9 months with the mean duration of symptoms ranging 6.2+/-3.0 months. 24% of the infants were born preterm. Snoring was the most common finding and appeared in all infants. Other symptoms were sleep apnea (72%), frequent movements during sleep (69%), mouth breathing (62%) and recurrent awakenings (38%). During the preoperative period, mean body weight decreased from the 67th+/-25 percentile to the 42nd+/-32 percentile (P<0.00001). 14/29 (48%) of the infants dropped two or more major percentiles before treatment. A significant weight gain to the 59th+/-31 percentile was observed post surgery (P<0.0001). 5/29 (17%) infants were considered by their parents as having a developmental delay preoperatively, which resolved in 3/5 (60%) post treatment. Clinical symptoms resolved or improved significantly after surgery. Recurrence of symptoms was documented in 6/23 (26%) of infants.
Conclusions:
Infantile OSAS due to hypertrophic adenoids and tonsils does occur in infants. Unique characteristics for this age group include: male predominance, high incidence of preterm infants, failure to gain weight and high recurrence rate after surgery. Otolaryngologists and pediatricians should be aware to the existence of the "early OSAS" in small infants.
Related Concept Videos
Tonsillitis I: Introduction
Etiology
Three primary contributing factors have been identified.
Sleep Apnea
The condition is more prevalent among...
Chronic Pharyngitis
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Tonsillitis II: Management
Cardiopulmonary Resuscitation II: ACLS Airway Management
Esophageal Achalasia
